Immunic Inc. (IMUX) Tops Q3 EPS by 4c

Immunic Inc. (NASDAQ: IMUX) reported Q3 EPS of ($0.51), $0.04 better than the analyst estimate of ($0.55).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• ArcelorMittal Q2 2026 analyst consensus: $2.04B EBITDA expected
• HCA Holdings (HCA) Tops Q2 EPS by 19c ; Offers Guidance